Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

899
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
899
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

692
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
692
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

576
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
576
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

467
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
467
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Desmin c.322G>A variant is associated with cardiomyopathy: a case series.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.

Circulation. Heart failure·2026
Same author

Tissue characterization in cardiac amyloidosis: a joint consensus document by the gruppo di studio di cardiopatologia (SIAPEC) and the SIC/ANMCO Italian cardiac amyloidosis network (RIAC).

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-study.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

[Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC)].

Giornale italiano di cardiologia (2006)·2026
Same author

Hyperkalemia, guideline-directed medical therapy and outcomes in heart failure patients followed at a tertiary center.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

A high proportion of children with severe cardiomyopathies show both myocarditis and genetic predispositions.

European journal of heart failure·2026
Same journal

Correction to: Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study.

European journal of heart failure·2026
Same journal

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same journal

"Reply to Murthy et al. regarding AI-derived LVOT-VTI for monitoring disease progression in transthyretin cardiac amyloidosis".

European journal of heart failure·2026
Same journal

High serum transthyretin concentrations identify a low likelihood of advanced myocardial amyloid burden in suspected ATTR cardiomyopathy.

European journal of heart failure·2026
Same journal

Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B Trial.

European journal of heart failure·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K

What can we learn from pulmonary function testing in heart failure?

Helgo Magnussen1, Marco Canepa2, Peter Emilio Zambito3

  • 1Pulmonary Research Institute at Lung Clinic Grosshansdorf and Airway Research Center North, Member of the German Center for Lung Research, Grosshansdorf, Germany.

European Journal of Heart Failure
|August 15, 2017
PubMed
Summary
This summary is machine-generated.

Pulmonary function testing aids cardiologists in managing heart failure (HF) patients with lung conditions. These tests help differentiate symptoms, predict outcomes, and guide treatment for better patient care.

Keywords:
Heart failurePulmonary diseasePulmonary function testingSpirometry

More Related Videos

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Related Experiment Videos

Last Updated: Feb 24, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Diagnostics

Background:

  • Heart failure (HF) frequently coexists with pulmonary diseases, creating diagnostic and therapeutic challenges.
  • Pulmonary function testing (PFT) offers valuable insights for managing these complex patients.
  • Portable PFT devices enable wider use in cardiology, though interpretation requires expertise.

Purpose of the Study:

  • To review PFT methodologies and interpretation in HF patients.
  • To explore PFT's role in differentiating cardiac vs. pulmonary symptoms and preventing decompensation.
  • To examine PFT's prognostic value and therapeutic guidance in HF with coexisting pulmonary disorders.

Main Methods:

  • Review of methodologies for spirometry and lung diffusion capacity.
  • Discussion of PFT interpretation in HF patients with and without pulmonary diseases.
  • Examination of recent evidence on PFT's prognostic and therapeutic implications.

Main Results:

  • PFT can differentiate cardiac and pulmonary symptoms, aiding in preventing acute cardiac decompensation.
  • PFT provides independent prognostic information in HF patients, regardless of pulmonary status.
  • PFT findings can inform therapeutic decisions, addressing treatment gaps in HF with coexisting lung diseases.

Conclusions:

  • Pulmonary function testing is a valuable tool for cardiologists managing heart failure patients with concurrent pulmonary conditions.
  • Interpreting PFT results is crucial for optimizing diagnosis, prognosis, and treatment strategies.
  • Wider adoption of PFT can improve outcomes for heart failure patients with complex comorbidities.